Dolutegravir-Based ART: Exploring Patient Safety and Acceptability Following National Roll-Out in Uganda
dc.contributor.author | Zakumumpa, Henry | |
dc.contributor.author | Kitutu, Freddy Eric | |
dc.contributor.author | Ndagije, Helen Bomire | |
dc.contributor.author | Nakitto-Kesi, Diana | |
dc.contributor.author | Nambi Ssanyu, Jacquellyn | |
dc.contributor.author | Kiguba, Ronald | |
dc.date.accessioned | 2022-01-28T11:41:02Z | |
dc.date.available | 2022-01-28T11:41:02Z | |
dc.date.issued | 2021 | |
dc.description.abstract | The World Health Organization recommends dolutegravir (DTG) as the backbone for rst-line and secondline antiretroviral therapy (ART) worldwide. However, little is known about the acceptability and tolerability of DTG-based ART at routine points-of-care in Uganda. We set out to explore the perceptions of ART clinic managers regarding the acceptability and tolerability of DTG-based ART since national roll-out in March 2018 in Uganda. We adopted a qualitative descriptive design involving 49 ART clinic managers and clinicians. Between September 2020 and February 2021, we conducted 22 in-depth interviews with ART clinic managers and clinicians in 12 purposively selected health facilities across Uganda. The selection of study sites ensured diversity in facility ownership-type (public/private), level of service delivery (tertiary/secondary/primary) and the four major geographic sub-regions of Uganda. We conducted three focus group discussions with 27 ART clinicians in the participating facilities. Data were analyzed by thematic approach. | en_US |
dc.identifier.citation | Zakumumpa, H., Kitutu, F. E., Ndagije, H. B., Diana, N. K., Ssanyu, J. N., & Kiguba, R. (2021). Dolutegravir-Based ART: Exploring Patient Safety and Acceptability Following National Roll-Out in Uganda. https://doi.org/10.21203/rs.3.rs-670284/v1 | en_US |
dc.identifier.uri | https://doi.org/10.21203/rs.3.rs-670284/v1 | |
dc.identifier.uri | https://nru.uncst.go.ug/xmlui/handle/123456789/1593 | |
dc.language.iso | en | en_US |
dc.publisher | Research Square | en_US |
dc.subject | ART | en_US |
dc.subject | Patient | en_US |
dc.subject | DTG | en_US |
dc.subject | Public | en_US |
dc.title | Dolutegravir-Based ART: Exploring Patient Safety and Acceptability Following National Roll-Out in Uganda | en_US |
dc.type | Article | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Dolutegravir-Based ART Exploring Patient Safety.pdf
- Size:
- 629.64 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: